This solicitation closed on May 13, 2026
View current Department of Defense opportunities →Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
AI Overview
Mobile diagnostic card interface for rapidly synthesizing stable nucleic acid reagents in extreme field conditions, enabling point-of-need test development without cold storage requirements and supporting molecular assay generation across challenging environmental scenarios.
This summary is AI-generated from the official solicitation.
Key Details
Official Description
The Chemical and Biological Defense Program (CBDP) faces a critical challenge: the need for rapid, deployable diagnostic capabilities in far forward or expeditionary environments. Maintaining the health and readiness of the total force hinges on the ability to rapidly develop and deploy diagnostic assays in response to emerging threats and infectious diseases. However, current technologies present significant limitations. Existing nucleic acid synthesizers rely on reagents that demand cold chain...
Change History
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Opportunity CBD254-010 no longer available
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Status changed from Open to Open
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
**No substantive changes detected.** The Previous and Updated Q&A sections are identical. All four Q&As and their answers remain unchanged. No new questions were added, no pending responses were resolved, and no answers were updated or clarified.
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
**Q&A Changes:** Added 1 new question (Q1) clarifying whether applicants can stabilize existing commercial reagents or must develop novel reagents from scratch. The answer emphasizes that innovation must be in novel chemistry and formulation of reagents themselves, not just stabilization of existing products.
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
No changes detected. The previous and updated Q&A sections are identical. All three Q&As and their answers remain the same.
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
# Q&A Changes Summary **New Answer Added:** Q1 clarified that the program focuses on shelf-stable reagent chemistry/formulation development, not specific synthesis platforms or nucleic acid types. Innovation must be in reagent chemistry applicable to large ssDNA synthesis.
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Status changed from Pre-Release to Open
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Close Date changed from 2026-03-04 to 2026-04-29
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Open Date changed from 2026-02-11 to 2026-04-01
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Close Date changed from 2026-02-25 to 2026-03-04
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Open Date changed from 2026-02-04 to 2026-02-11
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Close Date changed from 2026-02-11 to 2026-02-25
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Open Date changed from 2026-01-21 to 2026-02-04
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Close Date changed from 2026-02-04 to 2026-02-11
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Open Date changed from 2026-01-14 to 2026-01-21
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Q&A section updated
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Content updated: description, objective, phase_1_description, phase_2_description, phase_3_description
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Q&A section updated
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Content updated: description, objective, phase_1_description, phase_2_description, phase_3_description
Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics
Q&A section updated
Similar Opportunities
Next-Generation Non-Lithium Battery Technology for Safe, Extreme-Environment, High-Performance Resilient Military Logistics and Field Operations
Due July 22, 2026
ActiveDEVCOM and ERDC Onshoring Advanced Manufacturing Capabilities for High-Performance Vapor Barrier Technologies Prototype
Due July 13, 2026
Pre-ReleaseAdvanced Stand-Off Detection of Concealed Materials (ASDCM)
Due August 19, 2026
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial